Psoriasis Drugs Market Report

Psoriasis Drugs Market Analysis Report by Therapeutic Class (Interleukin-inhibitors, Tumor Necrosis Factor-inhibitors), by Treatment (Topicals, Systemic, Biologics), and Segment Forecasts, 2016 - 2022

  • Published Date: Sep, 2018
  • Base Year for Estimate: 2016
  • Report ID: GVR-1-68038-662-2
  • Format: Electronic (PDF)
  • Historical Data:
  • Number of Pages: 115

Market Segmentation

  • Psoriasis Drugs Therapeutic Class Outlook (Revenue, USD Million, 2016 - 2022)
    • Tumor Necrosis Factor Inhibitors
    • Interleukin Inhibitors
    • Vitamin-D Analogues
    • Others
  • Psoriasis Drugs Treatment Outlook (Revenue, USD Million, 2016 - 2022)
    • Topicals
    • Systemic
    • Biologics
  • Psoriasis Drugs Regional Outlook (Revenue, USD Million, 2016 - 2022)
    • The U.S.
      • The U.S. Psoriasis Drugs Market, by Therapeutic Class
        • Tumor Necrosis Factor inhibitors
        • Interleukin Inhibitors
        • Others
      • The U.S. Psoriasis Drugs Market, by Treatment
        • Topicals
        • Systemics
        • Biologics
    • The U.K.
      • The U.K. Psoriasis Drugs Market, by Therapeutic Class
        • Tumor Necrosis Factor inhibitors
        • Interleukin Inhibitors
        • Others
      • The U.K. Psoriasis Drugs Market, by Treatment
        • Topicals
        • Systemics
        • Biologics
    • Germany
      • Germany Psoriasis Drugs Market, by Therapeutic Class
        • Tumor Necrosis Factor inhibitors
        • Interleukin Inhibitors
        • Others
      • Germany Psoriasis Drugs Market, by Treatment
        • Topicals
        • Systemics
        • Biologics
    • Spain
      • Spain Psoriasis Drugs Market, by Therapeutic Class
        • Tumor Necrosis Factor inhibitors
        • Interleukin Inhibitors
        • Others
      • Spain Psoriasis Drugs Market, by Treatment
        • Topicals
        • Systemics
        • Biologics
    • France
      • France Psoriasis Drugs Market, by Therapeutic Class
        • Tumor Necrosis Factor inhibitors
        • Interleukin Inhibitors
        • Others
      • France Psoriasis Drugs Market, by Treatment
        • Topicals
        • Systemics
        • Biologics
    • Italy
      • Italy Psoriasis Drugs Market, by Therapeutic Class
        • Tumor Necrosis Factor inhibitors
        • Interleukin Inhibitors
        • Others
      • Italy Psoriasis Drugs Market, by Treatment
        • Topicals
        • Systemics
        • Biologics
    • Japan
      • Japan Psoriasis Drugs Market, by Therapeutic Class
        • Tumor Necrosis Factor inhibitors
        • Interleukin Inhibitors
        • Others
      • Japan Psoriasis Drugs Market, by Treatment
        • Topicals
        • Systemics
        • Biologics

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2016 to 2022
  • Market estimates and forecast for product segments up to 2022
  • Regional market size and forecast for product segments up to 2022
  • Market estimates and forecast for application segments up to 2022
  • Regional market size and forecast for application segments up to 2022
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.